Balaxi Pharmaceuticals Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Balaxi Pharmaceuticals.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 27.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues
Nov 13
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well
Jul 30Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk
May 29Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost
Feb 10Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet
Feb 09Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?
Aug 08The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested
May 20A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Feb 03Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)
Sep 06Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively
Jun 03Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 12Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 27
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Balaxi Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 2,636 | 356 | -25 | -51 | N/A |
| 6/30/2024 | 2,410 | 454 | N/A | N/A | N/A |
| 3/31/2024 | 2,413 | -24 | 42 | 49 | N/A |
| 12/31/2023 | 2,621 | -52 | N/A | N/A | N/A |
| 9/30/2023 | 2,879 | -106 | -199 | -99 | N/A |
| 6/30/2023 | 3,196 | -95 | N/A | N/A | N/A |
| 3/31/2023 | 3,364 | 460 | -70 | 61 | N/A |
| 12/31/2022 | 3,449 | 506 | N/A | N/A | N/A |
| 9/30/2022 | 3,200 | 545 | 262 | 362 | N/A |
| 6/30/2022 | 3,038 | 511 | N/A | N/A | N/A |
| 3/31/2022 | 2,794 | 477 | 288 | 341 | N/A |
| 12/31/2021 | 2,416 | 433 | N/A | N/A | N/A |
| 9/30/2021 | 2,457 | 421 | 31 | 56 | N/A |
| 6/30/2021 | 2,373 | 401 | N/A | N/A | N/A |
| 3/31/2021 | 2,313 | 381 | -13 | 0 | N/A |
| 12/31/2020 | 1,939 | 312 | N/A | N/A | N/A |
| 9/30/2020 | 1,411 | 228 | -53 | -39 | N/A |
| 6/30/2020 | 938 | 138 | N/A | N/A | N/A |
| 3/31/2020 | 456 | 61 | -142 | -140 | N/A |
| 12/31/2019 | 416 | 53 | N/A | N/A | N/A |
| 9/30/2019 | 342 | 40 | -93 | -93 | N/A |
| 6/30/2019 | 230 | 31 | N/A | N/A | N/A |
| 3/31/2019 | 140 | 20 | -15 | -15 | N/A |
| 12/31/2018 | 79 | 11 | N/A | N/A | N/A |
| 9/30/2018 | 15 | -3 | N/A | N/A | N/A |
| 6/30/2018 | N/A | -8 | N/A | N/A | N/A |
| 3/31/2018 | N/A | -8 | N/A | -7 | N/A |
| 12/31/2017 | -6 | -12 | N/A | N/A | N/A |
| 9/30/2017 | -6 | -11 | N/A | N/A | N/A |
| 6/30/2017 | -6 | -8 | N/A | N/A | N/A |
| 3/31/2017 | 0 | -2 | N/A | -1 | N/A |
| 12/31/2016 | 0 | -1 | N/A | N/A | N/A |
| 9/30/2016 | 0 | -1 | N/A | N/A | N/A |
| 6/30/2016 | 0 | -1 | N/A | N/A | N/A |
| 3/31/2016 | 0 | -1 | N/A | 0 | N/A |
| 12/31/2015 | 2 | -1 | N/A | N/A | N/A |
| 3/31/2015 | 2 | 1 | N/A | 2 | N/A |
| 3/31/2014 | 2 | 1 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BALAXI's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if BALAXI's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if BALAXI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BALAXI's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if BALAXI's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BALAXI's Return on Equity is forecast to be high in 3 years time